Skip to content

Ototoxicity in patients with Metal-on-Metal hip Arthroplasties

Ototoxicity in patients with Metal-on-Metal hip Arthroplasties - Ototoxicity with Metal-on-Metal hip bearings

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56425
Enrollment
450
Registered
2022-08-05
Start date
2023-03-24
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hearing loss ototoxicity

Interventions

None listed

Sponsors

Reinier de Graaf Groep
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All MoM patients from the different clinics Revision MoM Willing to participate Speak/write the Dutch language.

Exclusion criteria

Exclusion criteria: Not willing to participate Previous ENT surgery or ENT pathology

Design outcomes

Primary

MeasureTime frame
To assess the prevalence of damage to the auditory system in patients with a Metal-on-Metal or revised Metal-on-Metal bearing, especially regarding mid frequency hearing loss. A distinction will be made between prevalence in patients with high plasma cobalt or chromium levels and patients with low plasma cobalt and chromium levels.

Secondary

MeasureTime frame
To assess which factors are associated with damage to the auditory system (We will only perform this if possible, if we have enough cases with hearing loss). o Factors of interest: highest known cobalt plasma concentration, highest known chromium plasma concentration, type of prosthesis, age, work in a noisy environment, presence of ARDM, revision o Patients will be asked to complete the hearing questionnaire as well as the Metal-on-Metal Prosthesis Questionnaire for Assessing General Health in order determine the general health of these patients and subjective hearing loss.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)